Business
Todos Medical Reports Pre-Print of Publication Detailing Tollovid Supplementation Following COVID-19 mRNA Vaccination in Long COVID
Todos Medical Reports Pre-Print of Publication Detailing Tollovid Supplementation Following COVID-19 mRNA Vaccination in Long COVID.
About this update from Todos Medical Ltd.
[{"type":"text","content":"\n New York, NY, and Tel Aviv, ISRAEL, Aug. 15, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire -- Todos Medical, Ltd. (OTCQB: TOMDF), a comprehensive medical diagnostics and related solutions company, today announced that its majority-owned joint venture 3CL Pharma Ltd. reported the preprint in ResearchGate of a case study entitled “COVID-19 Vaccines are Necessary but not Sufficient”, overseen by Dr. Lee Morgentaler in concert with Andrew A. Blumenthal, RN ADS of two patients with Post-Acute Sequelae of COVID (PASC, or “Long COVID”) who  experienced limited benefit after vaccination, who subsequently experienced significant benefit after supplementation with 3CL protease inhibitor immune support supplement Tollovid™. The pre-publication can be viewed at: https://www.researchgate.net/publication/362694094_A_Case_Review_COVID-19_Vaccines_are_Necessary_but_not_Sufficient.  ABSTRACTMessenger RNA (mRNA) was discovered in the early 1960s and by the 1970s researchers developed technology enabling them to deliver mRNA directly into cells (Beyrer, 2021). mRNA vaccines function to increase protein translation and trigger a strong immune response against infectious disease targets. Recent animal models utilize mRNA vaccines to target influenza virus, Zika virus, and rabies virus. The first mRNA vaccine was developed against the Ebola virus, but Pfizer’s COVID-19 vaccine is the first mRNA product to achieve full FDA approval in the United States (Pardi, 2018). COVID-19 vaccines have decreased hospitalization and death rates significantly, but many studies have suggested vaccines offer less protection against lingering and chronic COVID-19 symptoms than expected (Reardon, 2022). There is an urgency for alternative solutions to provide protection against Long COVID. We present two cases in which individuals with viral persistence reported lingering COVID-19 symptoms, experienced adverse effects from the vaccine, and found significant relief after taking the plant-based dietary supplement Tollovid. To purchase Tollovid please visit Amazon or www.MyTollovid.com. About Tollovid™ and Tollovid Daily™ Tollovid and Tollovid Daily are oral dietary supplement products made from natural ingredients that help support and maintain healthy immune function and also have...